Skip to content
Search

Latest Stories

PB Conference: 'Installing technology at pharmacy is best way to enhance income, service'

Using innovation and technology is the best way for pharmacies to boost income and ensure efficiency in services, said tech-savvy pharmacist independent prescriber and contractor Amish Patel.

Patel has invested heavily in technological refurbishment at his pharmacy and was the first community pharmacy owner to have installed a dispensing robot in the UK eight years ago.


Highlighting the downward trend in pharmacies’ income, he said: “We know for the last five years plus, pharmacy income, pharmacy services -- they have just been reducing...

“We are still very heavily dependent on dispensing, and dispensing fees, and profit margins with the supply chain they have been ever reducing.

“This (using technology) has been a new way of generating new income. But again, just to highlight it is just enjoyment of pushing the boundaries what I can do personally.”

He added that using technology had made life easier not just for him but also for his staff, enabling them to introduce and manage a wide range of new services at Hodgson Pharmacy in Kent.

Citing a simple example of putting up screens to display offered services, he said, “It's been a great way of promoting things that we are doing.”

He added: “We can make the best use of technology to drive everything we are doing in the pharmacy.

“We also use a lot of technology for the booking system as well. It is simple and people can have access 24 hours and seven days a week to book appointments with the pharmacy. There is no need to call the pharmacy during the office hours. All this drives in efficiency, making my life easier.”

Talking about installing robots to support dispensing at his pharmacy, Patel said he had to choose between increasing the staff or look at ways of driving accuracy and efficiency-savings in the dispensing process. Hence, the first robot was installed way back in 2013.

He said: “Since the time we have the robot, we have zero down time, zero problems. It never goes sick, and is always on time in the morning. It is one of the best things I have invested in.”

Deploying technology has also enabled the firm to focus on a wide range of services that it offers today such as phlebotomy, private blood testing, ear wax removal by micro-suction, doing aesthetics and beautification, Patel said.

He added: “We are also offering online personal coaching services and weight loss services, as well as a whole variety of services where we are just expanding what we already know as pharmacists, and also applying new skill sets.”

Patel was interviewed by Michael Holden, the current chair of Pharmacy Business Conference, in Kent. The interview ran in the final session of the 6th annual Pharmacy Business Conference on Thursday, September 23.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less